Fish & Richardson

Contact
Share
Info
One Marina Park Drive
Boston, MA 02110-1878, United States
Phone: +1 (617) 368-2115
Fax: (617) 542-8906
Areas Of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Class Action
  • Commercial Law & Contracts
  • Communications & Media Law
  • Constitutional Law
  • Finance & Banking
  • Intellectual Property
  • International Law & Trade
  • Litigation
  • Products Liability
  • Science, Computers, & Tech
  • Transportation
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Delaware
  • Georgia
  • Massachusetts
  • Minnesota
  • New York
  • Texas
Other Countries
  • China
Number of Attorneys
200+ Attorneys

Biosimilars 2018 - A Year in Review

The U.S. biologics and biosimilars markets evolved rapidly in 2018. On January 17, life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel reviewed the U.S. market for biosimilar products and provide insights…more

Biosimilars, Inter Partes Review (IPR) Proceeding, Life Sciences, Patent Litigation

See all updates »

Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis

The Federal Circuit considered the relevance of an alleged infringer’s intent in a safe harbor analysis in Edwards Lifesciences Corp. v. Meril Life Scis. Pvt. The District Court had previously granted summary judgment that…more

Food and Drug Administration (FDA), Hatch-Waxman, Medical Devices, Patent Infringement, Patents

See all updates »

EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO

Challenges to the validity of the “Patent Cooperation Treaty joint applicant” have been a problem for many applicants at the European Patent Office. On October 10, 2023, the EPO’s highest authority, the Enlarged Board of Appeal,…more

EU, European Patent Convention, European Patent Office, Paris Convention, Patent Cooperation Treaty

See all updates »

Patent Local Rules: Knowing Them Well Can Make Litigating Your Case Smoother

Federal district courts throughout the country have enacted “patent local rules” that streamline how patent cases are litigated.  Here we provide a brief description of what they are, how they are applied, and some reasons why…more

Local Rules, Patent Litigation, Patents

See all updates »

Webinar | FTC Challenges to Orange Book Listings: Considerations for Patent Holders

On November 7, 2023, the Federal Trade Commission announced that it is challenging more than 100 patents held by 10 branded drug companies as improperly or inaccurately listed in the Food and Drug Administration's Orange Book…more

Federal Trade Commission (FTC), Food and Drug Administration (FDA), FTC Act, Life Sciences, Orange Book

See all updates »

An Introduction to Patent Due Diligence

A patent due diligence analysis can be an important and cost-effective tool for your company. It helps you determine the value of your own patent portfolio, including whether you can monetize your patents through licensing,…more

Due Diligence, Patent Portfolios, Patents

See all updates »

Webinar: 2018 Federal Circuit and Supreme Court Yearly Review

Recent Supreme Court decisions on intellectual property law have changed the world for intellectual property holders, and the Federal Circuit continues to shape the evolving legal landscape. Please join Fish attorneys John…more

Corporate Counsel, Patent Litigation, Patents, Post-Grant Review, USPTO

See all updates »

IP and Cannabis: The Current Landscape

Cannabis is a rapidly growing industry; in 2019, overall sales of cannabis products legal under state law were estimated to be worth $13.6 billion, with an expected increase to $29.7 billion by 2025. While marijuana remains a…more

Cannabidiol (CBD) oil, Cannabis Products, Controlled Substances, Cosmetics, Dietary Supplements

See all updates »

Patent Portfolio Management: Strategies for Navigating Due Diligence for Startups

Patent due diligence is an imperative tool for businesses to assess the risks associated with transferring and/or acquiring patents. This process aims to identify potential validity, enforceability, and infringement issues…more

Due Diligence, Patent Filings, Patent Infringement, Patent Ownership, Patent Portfolios

See all updates »

USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

One year ago, the United States Patent and Trademark Office (USPTO) issued an Advance Notice of Proposed Rulemaking (ANPRM) that set forth several ideas related to America Invents Act (AIA) proceedings before the Patent Trial…more

Administrative Procedure, Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Inter Partes Review (IPR) Proceeding, NPRM

See all updates »

District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit

As part of the Hatch-Waxman Act, given the lack of information on the allegedly infringing product, courts have found that patentees can satisfy the pleading requirements of Twombly/Iqbal without having access to the accused…more

Abbreviated New Drug Application (ANDA), Federal Rules of Civil Procedure, Hatch-Waxman, Novartis, Orange Book

See all updates »

What’s New in Director Review?

In July, the United States Patent and Trademark Office announced several changes to the interim process for Director review of Patent Trial and Appeal Board decisions. Originally established shortly after the Supreme Court’s…more

Administrative Appeals, Administrative Review, Directors, Patent Trial and Appeal Board, PTAB Precedential Opinion Panel (POP)

See all updates »

What is Patentable Subject Matter?

Patent eligibility is the first of three hurdles to be cleared in obtaining a patent (the other two are novelty and non-obviousness). This post is the first of a series that provides a digest of the law of…more

Patent Act, Patent-Eligible Subject Matter, Patents

See all updates »

Texas Patent Litigation Monthly Wrap-Up: December 2022

The update for December 2022 summarizes three patent decisions that issued from the Western District of Texas. These three decisions all evaluated challenges to venue in patent suits. In the end, the court transferred two of the…more

Apple, Motion to Transfer, Patent Infringement, Patent Litigation, Patents

See all updates »

Hatch-Waxman 101

Pharmaceutical patents have proven to be a highly effective incentive for groundbreaking innovation. However, corresponding drug prices have long been an animating issue in American law and policy…more

Abbreviated New Drug Application (ANDA), Food and Drug Administration (FDA), Hatch-Waxman, Life Sciences, Patents

See all updates »

ITC Monthly Wrap-Up: November 2021

November brought another busy month for the ITC. Final Determinations were issued by the Commission in two Section 337 Investigations: Certain Electronic Devices, Including Streaming Players, Televisions, Set Top Boxes, Remote…more

Administrative Law Judge (ALJ), Electronic Devices, International Trade Commission (ITC), IP Litigation, Roku

See all updates »

Massachusetts Patent Litigation Wrap Up – April 2020

This post is a part of a monthly series summarizing notable activity in patent litigation in the District of Massachusetts, including short summaries of substantive orders. As a general matter, the public emergency arising out…more

Patent Litigation, Patents

See all updates »

The Federal Circuit Weighs in On Hatch-Waxman “Skinny” Label Infringement Dispute

The Hatch-Waxman Act allows a generic drugmaker to rely on a branded drugmaker’s Food and Drug Administration-approved New Drug Application if the generic drugmaker can show that the generic drug has the same active ingredient…more

Contributory Infringement, Hatch-Waxman, Life Sciences, Patent Infringement, Patent Litigation

See all updates »

Texas Patent Litigation Monthly Wrap-Up: March 2023

March's Texas Patent Litigation Monthly Wrap-Up covers decisions addressing post-verdict JMOL, the point at which cases become exceptional, and the standard for amending invalidity contentions, among other issues…more

Damages, Exceptional Case, JMOL, Motion for JMOL, Patent Infringement

See all updates »

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant…more

Biologics, Biosimilars, BPCIA, Drug Approvals, FDA Approval

See all updates »

Webinar | Trademark & Copyright 2023 Year in Review

2023 brought several notable developments in trademark and copyright law, including cases that touched on artificial intelligence and generative AI, copyright fair use, and the extraterritorial application of the Lanham Act. On…more

Andy Warhol Foundation for the Visual Arts Inc v Goldsmith, Intellectual Property Protection, Jack Daniels Properties Inc v VIP Products LLC, Lanham Act, Rogers Test

See all updates »

What’s New in Director Review? Lessons From the Delegated Rehearing Panel’s First Decisions

The Director of the United States Patent and Trademark Office (USPTO) established the interim process for Director Review of Patent Trial and Appeal Board (PTAB) decisions in the wake of the Supreme Court’s 2021 decision in…more

America Invents Act, Claim Construction, Patent Prosecution History, Patent Trial and Appeal Board, Patents

See all updates »

ITC Monthly Wrap-Up: August 2023

In August 2023, one complainant filed a new complaint for a violation of Section 337 in the International Trade Commission. Specifically, on August 22, NJOY, LLC, filed a complaint against JUUL Labs, Inc., in Vaporizer Devices,…more

Claim Construction, Imports, International Trade, International Trade Commission (ITC), Investigations

See all updates »

Antitrust Issues with "No-Poaching" Agreements

A client is negotiating a software license agreement to license in some information technology (IT) services from a service provider. The IT services were going to be a quantum improvement for our client, and they were investing…more

Corporate Counsel, Department of Justice (DOJ), Employee Retention, Employees, Federal Trade Commission (FTC)

See all updates »

Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis

The Federal Circuit considered the relevance of an alleged infringer’s intent in a safe harbor analysis in Edwards Lifesciences Corp. v. Meril Life Scis. Pvt. The District Court had previously granted summary judgment that…more

Food and Drug Administration (FDA), Hatch-Waxman, Medical Devices, Patent Infringement, Patents

See all updates »

Webinar | Intellectual Property Protection for Defense Contractors

There is no shortage of innovation among defense contractors, with equipment and technology steadily increasing in complexity and countless industries being proven to have a defense industrial base. Nevertheless, intellectual…more

Defense Contracts, Defense Sector, Department of Defense (DOD), Federal Contractors, Intellectual Property Protection

See all updates »

Judge Connolly’s New Standing Order Requiring Disclosure Behind Patent Assertion Entities Is Showing It Has Teeth

On August 17, 2022, Chief Judge Colm F. Connolly of the District of Delaware issued an order in which he questioned the sufficiency of the plaintiff’s disclosure of financially interested parties in Longbeam Technologies LLC. v…more

Disclosure Requirements, Federal Rules of Civil Procedure, Federal Trade Commission (FTC), Fee-Shifting, IP License

See all updates »

Unified Patent Court and Unitary Patent Moving Ahead in Europe

Final preparations by sixteen EU member states for their Unified Patent Court (UPC) and Unitary Patent (UP) began on 19 January 2022, following Austria’s deposit on the previous day of its ratification of the Protocol on…more

Advisory Committee, EU, Intellectual Property Protection, Member State, Patents

See all updates »

Supreme Court Rules § 315(b) Time Bar Decisions Are Not Appealable in Thryv v. Click-to-Call

The Supreme Court ruled today in Thryv, Inc. v. Click-to-Call Technologies, LP that decisions that an inter partes review petition was timely filed cannot be appealed. In a 7-2 decision penned by Justice Ginsburg, the Court held…more

§ 314(d), § 315(b), §314(a), §314(b), America Invents Act

See all updates »

ITC Monthly Wrap-Up: December 2023

This month’s ITC Wrap-Up reviews a recent investigation exploring exemptions to the Commission’s remedial orders. Certain Wet Dry Surface Cleaning Devices, Inv. No. 337-TA-1304, Final Determination (Dec. 18, 2023)…more

Administrative Law Judge (ALJ), Ericsson, International Trade Commission (ITC), Investigations, Motorola

See all updates »

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant…more

Biologics, Biosimilars, BPCIA, Drug Approvals, FDA Approval

See all updates »

Everything You Need to Know About Patent Maintenance Fees

What are patent maintenance fees? Patent maintenance fees are mandatory fees that must be paid to the United States Patent and Trademark Office (“USPTO”) at certain time points after a patent issues in order to keep a utility…more

Maintenance Fees, Patents, USPTO

See all updates »

2022 Post-Grant Annual Report

2022 was a milestone year for the Patent Trial and Appeal Board. In April, Kathi Vidal began her tenure as Director of the United States Patent and Trademark Office with an early focus on promoting increased efficiency at the…more

America Invents Act, Final Written Decisions, Inter Partes Review (IPR) Proceeding, Obviousness, Patent Litigation

See all updates »

Webinar | Patent Strategies for Bioinformatics and Genomics Inventions

Bioinformatics and computational genomics have become increasingly important for biological and genomic research, and artificial intelligence (AI) has the potential to revolutionize these industries. The use of AI in…more

Artificial Intelligence, Bioinformatics, Bioinformatics Patents, Biotechnology, Business Strategies

See all updates »

Webinar | Addressing Bias in the Legal Industry

The average person makes an estimated 35,000 decisions each day. With our unconscious minds driving many of these decisions, both conscious and unconscious biases are a powerful force in shaping our behavior. In this webinar,…more

Bias, Defense Strategies, Intellectual Property Litigation, Intellectual Property Protection, Jury Trial

See all updates »

EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO

Challenges to the validity of the “Patent Cooperation Treaty joint applicant” have been a problem for many applicants at the European Patent Office. On October 10, 2023, the EPO’s highest authority, the Enlarged Board of Appeal,…more

EU, European Patent Convention, European Patent Office, Paris Convention, Patent Cooperation Treaty

See all updates »

Webinar: 2018 Federal Circuit and Supreme Court Yearly Review

Recent Supreme Court decisions on intellectual property law have changed the world for intellectual property holders, and the Federal Circuit continues to shape the evolving legal landscape. Please join Fish attorneys John…more

Corporate Counsel, Patent Litigation, Patents, Post-Grant Review, USPTO

See all updates »

Webinar | Design Patents at the PTAB

In-depth knowledge of the unique characteristics of design patents is foundational for preparing a strong Patent Trial and Appeal Board petition. In the second installment of our three-part design patent webinar series,…more

Design Patent, Patent Trial and Appeal Board, Post-Grant Review, USPTO

See all updates »

USPTO Proposes New Amendment Procedure for America Invents Act

Director Iancu proposed a new amendment procedure on Thursday, October 25. The Director indicates that his proposed changes to the existing amendment practice were intended to avail patent owners of a more viable option for…more

America Invents Act, Comment Period, Patents, Proposed Amendments, USPTO

See all updates »

Middle District of North Carolina Finds Public Interest Favors Granting Preliminary Injunction

On December 27, 2023, Chief Judge Catherine Eagles of the U.S. District Court for the Middle District of North Carolina granted a motion for preliminary injunction by Natera Inc. enjoining NeoGenomics Laboratories Inc. from…more

Abbreviated New Drug Application (ANDA), Genetic Materials, Genetic Testing, Hatch-Waxman, Irreparable Harm

See all updates »

Webinar | Federal Circuit 2023 Year in Review

In 2023, the U.S. Court of Appeals for the Federal Circuit issued a number of opinions that practitioners may have missed but nonetheless should familiarize themselves with, as they are likely to have major impacts on the…more

Claim Construction, Design Patent, Intellectual Property Litigation, Intellectual Property Protection, Inter Partes Review (IPR) Proceeding

See all updates »

What’s New in Director Review?

In July, the United States Patent and Trademark Office announced several changes to the interim process for Director review of Patent Trial and Appeal Board decisions. Originally established shortly after the Supreme Court’s…more

Administrative Appeals, Administrative Review, Directors, Patent Trial and Appeal Board, PTAB Precedential Opinion Panel (POP)

See all updates »

Webinar | Best Practices for Noninfringing Redesign

Software and hardware product development always comes with a risk of patent infringement litigation, which can result in damages awards, exclusion orders, and, in some cases, injunctions. A finding of patent infringement can…more

Intellectual Property Protection, Life Sciences, Noninfringement, Patent Infringement, Patent Litigation

See all updates »

Texas Patent Litigation Monthly Wrap-Up: October 2023

The Texas Patent Litigation Monthly Wrap-Up for October 2023 covers three decisions addressing the scope of the work-product and attorney-client privileges, limits on the use of a defendant’s use of its own patents during trial,…more

Claim Construction, Discovery Disputes, Document Productions, Jury Instructions, Jury Trial

See all updates »

Webinar | Patent Strategies for Bioinformatics and Genomics Inventions

Bioinformatics and computational genomics have become increasingly important for biological and genomic research, and artificial intelligence (AI) has the potential to revolutionize these industries. The use of AI in…more

Artificial Intelligence, Bioinformatics, Bioinformatics Patents, Biotechnology, Business Strategies

See all updates »

Germany Ratifies UPC Agreement; UP & UPC to Begin 1 June

On February 17, Germany ratified the UPC Agreement, launching the countdown to the beginning of the Unitary Patent and Unified Patent Court. Germany’s ratification means that the Agreement will enter into force on 1 June 2023…more

EU, Germany, Patents, Unified Patent Court, Unitary Patent

See all updates »

Webinar | Best Practices for Noninfringing Redesign

Software and hardware product development always comes with a risk of patent infringement litigation, which can result in damages awards, exclusion orders, and, in some cases, injunctions. A finding of patent infringement can…more

Intellectual Property Protection, Life Sciences, Noninfringement, Patent Infringement, Patent Litigation

See all updates »

Legal Alert: New Local Patent Rule in District of Massachusetts

Effective June 1, 2018, the District of Massachusetts has adopted a new Local Patent Rule 16.6. The new rule is the result of a multi-year process and is a comprehensive revision of the rule. It will apply to all patent cases in…more

Claim Construction, Local Patent Rules, Patent Infringement, Patent Litigation, Patents

See all updates »

ITC Litigation: Introduction to Trade Secret Protection at the ITC

We have covered several introductory topics about 337 Investigations at the International Trade Commission (ITC) through the lens of its most common context—as another forum for patent litigation…more

International Trade Commission (ITC), Investigations, Patent Infringement, Patents, Trade Secrets

See all updates »

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

On December 7, the Biden administration announced a proposed framework for determining whether the government may exercise its march-in rights to license pharmaceutical patents to third parties if it determines that the price of…more

Bayh-Dole Act, Biden Administration, Life Sciences, March-in-Rights, Patents

See all updates »

Navigating SuperGuide at the PTAB

Over the past 20 years, the Federal Circuit’s opinion in SuperGuide Corp. v. DirectTV Enters., Inc., 358 F.3d 870 (Fed. Cir. 2004), which defined the plain and ordinary meaning of the phrase “at least one of” followed by a…more

Claim Construction, Patent Litigation, Patent Trial and Appeal Board, Patents

See all updates »

ITC Monthly Wrap-Up: May 2023

In May, there were two new complaints filed at the U.S. International Trade Commission, including complaints filed by Efficient Power Conversion Corp. (Semiconductor Devices and Products Containing the Same) and Shoals…more

Contributory Infringement, Indirect Infringement, Infringement, International Trade, International Trade Commission (ITC)

See all updates »

USPTO Says AI-Assisted Inventions Not Categorically Unpatentable in New Guidance

Is an invention developed with the assistance of artificial intelligence (AI) patentable? On February 13, the United States Patent and Trademark Office (USPTO) issued guidance that helps to answer this question while also…more

Artificial Intelligence, Computer-Related Inventions, Innovative Technology, Intellectual Property Protection, Inventions

See all updates »

ITC Monthly Wrap-Up: December 2021

Unlocking A Public Interest Exemption Based On A Questionnaire - Synopsis: Upon consideration of the public interest factors, the Commission recently allowed the use of a questionnaire to demonstrate a “documented need” for…more

Administrative Law Judge (ALJ), Imports, International Trade Commission (ITC), Patent Infringement, Patents

See all updates »

Webinar | Design Patent Litigation

The law surrounding validity, infringement, claim construction, and damages in the design patent context is notably less developed than in the utility patent context. Nevertheless, courts have fashioned a robust body of case law…more

Claim Construction, Design Patent, Intellectual Property Litigation, Intellectual Property Protection, Patent Infringement

See all updates »

Federal Circuit Finds Digital Camera an Abstract Idea

The Federal Circuit’s recent precedential decision in Yu v. Apple reflects an important data point in the Court’s § 101 jurisprudence as it applies to patents claiming computer-implemented inventions. ___ F.3d ___, 2021 WL…more

Abstract Ideas, Patent Infringement, Patent Litigation, Patents

See all updates »

Antitrust Issues with "No-Poaching" Agreements

A client is negotiating a software license agreement to license in some information technology (IT) services from a service provider. The IT services were going to be a quantum improvement for our client, and they were investing…more

Corporate Counsel, Department of Justice (DOJ), Employee Retention, Employees, Federal Trade Commission (FTC)

See all updates »

Watch Where You Launch: Existing Space Laws Complicate Earthly IP Rights

Crew Dragon, a NASA commissioned, SpaceX designed capsule, successfully completed the first water landing since 1975 on August 2, 2020. “Thanks for flying SpaceX,” one SpaceX engineer commented following the two-month-long trip…more

International Treaties, NASA, Outer Space, SpaceX

See all updates »

TTAB Rules Consumer Perception Remains the Critical Inquiry for Generic.gTLD Marks

In June 2020, the U.S. Supreme Court rejected a rule that the combination of a generic term and a generic top-level domain (“gTLD”) is per se generic. See USPTO v. Booking.com B.V., 140 S. Ct. 2298 (2020) (“Booking.com”). In so…more

Examination Procedures, Generic Marks, gTLD, Trademark Litigation, Trademark Registration

See all updates »

USPTO Issues Proposed Rules on Director Review

On April 16, the United States Patent and Trademark Office (USPTO) published a Notice of Proposed Rulemaking (NPRM) regarding Director Review of Patent Trial and Appeal Board (PTAB) decisions…more

Administrative Review, NPRM, Patent Trial and Appeal Board, Patents, Proposed Rules

See all updates »

Webinar | Federal Circuit 2023 Year in Review

In 2023, the U.S. Court of Appeals for the Federal Circuit issued a number of opinions that practitioners may have missed but nonetheless should familiarize themselves with, as they are likely to have major impacts on the…more

Claim Construction, Design Patent, Intellectual Property Litigation, Intellectual Property Protection, Inter Partes Review (IPR) Proceeding

See all updates »

Webinar | Intellectual Property Protection for Defense Contractors

There is no shortage of innovation among defense contractors, with equipment and technology steadily increasing in complexity and countless industries being proven to have a defense industrial base. Nevertheless, intellectual…more

Defense Contracts, Defense Sector, Department of Defense (DOD), Federal Contractors, Intellectual Property Protection

See all updates »

The Top Three Things Foreign Companies Should Keep in Mind When Considering IPR

Being sued for patent infringement in the U.S. can be confusing, especially for foreign companies with limited litigation experience. Even more confusing are the multiple options and venues available for responding to patent…more

Administrative Law Judge (ALJ), Burden of Proof, Foreign Entities, Inter Partes Review (IPR) Proceeding, Litigation Strategies

See all updates »

USPTO Says AI-Assisted Inventions Not Categorically Unpatentable in New Guidance

Is an invention developed with the assistance of artificial intelligence (AI) patentable? On February 13, the United States Patent and Trademark Office (USPTO) issued guidance that helps to answer this question while also…more

Artificial Intelligence, Computer-Related Inventions, Innovative Technology, Intellectual Property Protection, Inventions

See all updates »

Webinar | Intellectual Property Protection for Defense Contractors

There is no shortage of innovation among defense contractors, with equipment and technology steadily increasing in complexity and countless industries being proven to have a defense industrial base. Nevertheless, intellectual…more

Defense Contracts, Defense Sector, Department of Defense (DOD), Federal Contractors, Intellectual Property Protection

See all updates »

Minnesota Patent Litigation Wrap-Up: Q3 2023

This post continues our summary of substantive orders in patent litigation in the District of Minnesota. This summary includes a motion to compel production of chemical intermediates from an overseas manufacturer in…more

Bristol-Myers Squibb, Foreign Corporations, Motion to Compel, Patent Infringement, Patent Litigation

See all updates »

USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

One year ago, the United States Patent and Trademark Office (USPTO) issued an Advance Notice of Proposed Rulemaking (ANPRM) that set forth several ideas related to America Invents Act (AIA) proceedings before the Patent Trial…more

Administrative Procedure, Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Inter Partes Review (IPR) Proceeding, NPRM

See all updates »

Blockchain and Cryptocurrency: What is Blockchain Technology?

Blockchain and cryptocurrency technologies are rapidly expanding throughout the world – and with that rapid expansion has come a growing interest in IP protection for blockchain and cryptocurrency inventions. USPTO statistics…more

Bitcoin, Blockchain, Cryptocurrency, Patents, USPTO

See all updates »

USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

One year ago, the United States Patent and Trademark Office (USPTO) issued an Advance Notice of Proposed Rulemaking (ANPRM) that set forth several ideas related to America Invents Act (AIA) proceedings before the Patent Trial…more

Administrative Procedure, Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Inter Partes Review (IPR) Proceeding, NPRM

See all updates »

Webinar | Biosimilars 2023 Year in Review

Since the passage of the Biologics Price Competition and Innovation Act, the field of biosimilars has expanded and evolved. Keeping abreast of these changes helps stakeholders understand future opportunities. On January 30,…more

Biologics, Biosimilars, Intellectual Property Protection, Life Sciences, Litigation Strategies

See all updates »

Potential Ways for Avoiding the Presumption of Prosecution History Estoppel of an Allowable Dependent Claim Depending from a Rejected Independent Claim

I. Introduction - The presumption of prosecution history estoppel is difficult to overcome. This presumption typically arises when a claim is rejected over the prior art and is then amended (limited) to overcome the rejection…more

Prosecution History Estoppel

See all updates »

Webinar | Exploring Common Interest Privilege

Common interest privilege allows parties who share a common legal interest to share information with their respective legal counsel without waiving attorney-client or work product privilege. Establishing common interest…more

Common-Interest Privilege, Confidential Communications, Evidence, Litigation Strategies, Motion to Compel

See all updates »

Webinar | How Standardization, SEPs, and Patent Pools Can Benefit the EV and Battery Industries

Technical standards are industry norms that enable interoperability, promote safety, and create economies of scale. While technical standards are intended to be implemented on a wide scale in the mass consumer market, many…more

Charging Stations, Electric Vehicles, Intellectual Property Protection, IP License, Lithium Batteries

See all updates »

Antitrust Issues with "No-Poaching" Agreements

A client is negotiating a software license agreement to license in some information technology (IT) services from a service provider. The IT services were going to be a quantum improvement for our client, and they were investing…more

Corporate Counsel, Department of Justice (DOJ), Employee Retention, Employees, Federal Trade Commission (FTC)

See all updates »

Criminal Theft of Trade Secrets

Trade secrets are one of the four major types of intellectual property and have many unique features, a number of which we have covered in other blogs. Unlike patents, which can only be enforced by private parties in civil…more

Criminal Liability, Theft, Trade Secrets, Unauthorized Access, Wire Fraud

See all updates »

Everything You Need to Know About Patent Maintenance Fees

What are patent maintenance fees? Patent maintenance fees are mandatory fees that must be paid to the United States Patent and Trademark Office (“USPTO”) at certain time points after a patent issues in order to keep a utility…more

Maintenance Fees, Patents, USPTO

See all updates »

Webinar | Post-Grant for Practitioners: Evidentiary Extravaganza

Presenting arguments without supporting evidence can spell disaster in an inter partes review. So you'd better know what evidence to use, when it's appropriate, and how to wield the available evidentiary tools most…more

Evidence, Expert Testimony, Intellectual Property Litigation, Inter Partes Review (IPR) Proceeding, Prior Art

See all updates »

Supreme Court to Resolve Copyright Registration Circuit Split

On June 28, the Supreme Court announced that it will address the long-standing circuit split regarding the Copyright Act’s prerequisite for copyright infringement suits. Although a copyright registration is not required for…more

Copyright, Copyright Infringement, Copyright Litigation, Copyright Registration, Corporate Counsel

See all updates »

What the FTC’s Ban on Noncompete Agreements Means for Trade Secrets

On April 23, the Federal Trade Commission (FTC) issued a final rule that would ban the use of noncompete agreements in most employment contracts nationwide. Hailed by the Commission as a measure to promote competition, protect…more

Confidential Information, Employment Contract, Federal Trade Commission (FTC), Final Rules, Former Employee

See all updates »

Webinar | Drafting Claims to Survive Hatch-Waxman Litigation

Enacted by Congress in 1984, the Hatch-Waxman Act balances the need for lower-cost prescription drugs and the protection of pharmaceutical innovations. While Hatch-Waxman litigation does not officially begin until the patent…more

Hatch-Waxman, Intellectual Property Protection, Life Sciences, Patent Infringement, Patent Litigation

See all updates »

IP and Cannabis: The Current Landscape

Cannabis is a rapidly growing industry; in 2019, overall sales of cannabis products legal under state law were estimated to be worth $13.6 billion, with an expected increase to $29.7 billion by 2025. While marijuana remains a…more

Cannabidiol (CBD) oil, Cannabis Products, Controlled Substances, Cosmetics, Dietary Supplements

See all updates »

Supreme Court Finds BOOKING.COM Protectable; Rejects “Sweeping Rule” Denying Protection to “generic.com” Marks

The Supreme Court held last week that BOOKING.COM—when used in connection with hotel reservation services—is not generic, rejecting the USPTO’s “sweeping rule” that a combination of a generic word and “.com” is generic. The…more

Acquired Distinctiveness, Appeals, Booking.com, Domain Name Registration, Domain Names

See all updates »

Webinar | Open Source Software, Patents, and the Question of Compatibility

Open source software has become an integral part of the software development industry. Leveraging the combined skills of an open source developer community often leads to improved time-to-market and lower costs for both…more

Intellectual Property Protection, Open Source Software, Software Developers, Software Licenses

See all updates »

Navigating SuperGuide at the PTAB

Over the past 20 years, the Federal Circuit’s opinion in SuperGuide Corp. v. DirectTV Enters., Inc., 358 F.3d 870 (Fed. Cir. 2004), which defined the plain and ordinary meaning of the phrase “at least one of” followed by a…more

Claim Construction, Patent Litigation, Patent Trial and Appeal Board, Patents

See all updates »

Webinar | Post-Grant 2023 Year in Review

?While total petition filings continued to decline in FY 2023, overall it was a dynamic year at the Patent Trial and Appeal Board. We saw proposals from both Capitol Hill and the United States Patent and Trademark Office that…more

Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Claim Construction, Intellectual Property Protection, Life Sciences

See all updates »

Navigating SuperGuide at the PTAB

Over the past 20 years, the Federal Circuit’s opinion in SuperGuide Corp. v. DirectTV Enters., Inc., 358 F.3d 870 (Fed. Cir. 2004), which defined the plain and ordinary meaning of the phrase “at least one of” followed by a…more

Claim Construction, Patent Litigation, Patent Trial and Appeal Board, Patents

See all updates »

The Return of Opinions of Counsel in Patent Cases: How Recent Judicial Decisions Have Made Them Relevant Once More

What should a prudent corporate executive do when he or she becomes aware that the corporation’s activities might be alleged to be infringing a United States patent? Some recent Supreme Court decisions have led to a revival of…more

Halo v Pulse, Patent Infringement, Patent Litigation, Patents, Willful Infringement

See all updates »

Webinar | A Deeper Dive Into the EU Unified Patent Court

How does the EU's new Unified Patent Court and Unitary Patent system compare with the existing patent protection system in Europe, especially in Germany, where the greatest number of patents are enforced? On February 28,…more

EU, European Patent Office, Unified Patent Court, Unified Patent System, Unitary Patent

See all updates »

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant…more

Biologics, Biosimilars, BPCIA, Drug Approvals, FDA Approval

See all updates »

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

On December 7, the Biden administration announced a proposed framework for determining whether the government may exercise its march-in rights to license pharmaceutical patents to third parties if it determines that the price of…more

Bayh-Dole Act, Biden Administration, Life Sciences, March-in-Rights, Patents

See all updates »

IP and Cannabis: The Current Landscape

Cannabis is a rapidly growing industry; in 2019, overall sales of cannabis products legal under state law were estimated to be worth $13.6 billion, with an expected increase to $29.7 billion by 2025. While marijuana remains a…more

Cannabidiol (CBD) oil, Cannabis Products, Controlled Substances, Cosmetics, Dietary Supplements

See all updates »

Texas Patent Litigation Monthly Wrap-Up: January 2023

The Texas patent litigation monthly update for January 2023 summarizes one patent decision that issued from the Western District of Texas. This decision is one of the first Rule 12(b)(6) motions to dismiss granted in a patent…more

Federal Rule 12(b)(6), Patent Infringement, Patent Litigation, Patents, Willful Infringement

See all updates »

New Admission Criteria to Practice Before USPTO Designed to Foster Diversity and Promote Innovation

On May 16, 2023, the United States Patent and Trademark Office published a Federal Register Notice outlining its newly expanded admission criteria for registration to practice before the office. These changes followed an October…more

Admissions, Bar Admission, Comment Period, Request for Admissions, USPTO

See all updates »

The Importance of Candor in PTAB Practice

On November 6, 2019, Fish & Richardson Principal Stuart Nelson and Associate Kim Leung hosted the Post-Grant for Practitioners webinar “USPTO Ethics Rules at the PTAB.” The webinar highlighted some of the major ethics rules at…more

Claim Construction, Inter Partes Review (IPR) Proceeding, Patent Trial and Appeal Board, Patents, Real Party in Interest

See all updates »

EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO

Challenges to the validity of the “Patent Cooperation Treaty joint applicant” have been a problem for many applicants at the European Patent Office. On October 10, 2023, the EPO’s highest authority, the Enlarged Board of Appeal,…more

EU, European Patent Convention, European Patent Office, Paris Convention, Patent Cooperation Treaty

See all updates »

Webinar | Protecting Your Femtech IP

Femtech is a growing industry that develops solutions to women’s healthcare issues that historically have been underfunded, under researched, and misunderstood. It focuses primarily on conditions that present differently in…more

Healthcare, Intellectual Property Protection, Medical Devices, Pharmaceutical Industry, Software

See all updates »

FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

On November 7, the Federal Trade Commission announced that it is challenging more than 100 patents held by 10 branded drug companies as improperly or inaccurately listed in the Food and Drug Administration’s Orange Book. The…more

Competition, Enforcement Actions, FDA Approval, Federal Trade Commission (FTC), Food and Drug Administration (FDA)

See all updates »

Marking and Pre-Suit Damages: What Happens when a Failure to Mark Is Followed by a Period of Compliance with the Marking Statute?

A question that arises with some frequency in modern patent infringement cases is: Can pre-suit damages be recovered for a time period when the patentee (and any licensee) was in compliance with the marking statute when there…more

Damages, IP License, Non-Practicing Entities, Patent Infringement, Patent Litigation

See all updates »

Texas Patent Litigation Monthly Wrap-Up: September 2022

This post reviews three recent Texas district court opinions regarding venue under 28 U.S.C. § 1400 et seq…more

Mercedes-Benz, Patent Infringement, Patent Litigation, Patents, Samsung

See all updates »

Webinar | Trademark & Copyright 2023 Year in Review

2023 brought several notable developments in trademark and copyright law, including cases that touched on artificial intelligence and generative AI, copyright fair use, and the extraterritorial application of the Lanham Act. On…more

Andy Warhol Foundation for the Visual Arts Inc v Goldsmith, Intellectual Property Protection, Jack Daniels Properties Inc v VIP Products LLC, Lanham Act, Rogers Test

See all updates »

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

On December 7, the Biden administration announced a proposed framework for determining whether the government may exercise its march-in rights to license pharmaceutical patents to third parties if it determines that the price of…more

Bayh-Dole Act, Biden Administration, Life Sciences, March-in-Rights, Patents

See all updates »

USPTO Says AI-Assisted Inventions Not Categorically Unpatentable in New Guidance

Is an invention developed with the assistance of artificial intelligence (AI) patentable? On February 13, the United States Patent and Trademark Office (USPTO) issued guidance that helps to answer this question while also…more

Artificial Intelligence, Computer-Related Inventions, Innovative Technology, Intellectual Property Protection, Inventions

See all updates »

Webinar | Trademark & Copyright 2023 Year in Review

2023 brought several notable developments in trademark and copyright law, including cases that touched on artificial intelligence and generative AI, copyright fair use, and the extraterritorial application of the Lanham Act. On…more

Andy Warhol Foundation for the Visual Arts Inc v Goldsmith, Intellectual Property Protection, Jack Daniels Properties Inc v VIP Products LLC, Lanham Act, Rogers Test

See all updates »

The Federal Circuit Weighs in On Hatch-Waxman “Skinny” Label Infringement Dispute

The Hatch-Waxman Act allows a generic drugmaker to rely on a branded drugmaker’s Food and Drug Administration-approved New Drug Application if the generic drugmaker can show that the generic drug has the same active ingredient…more

Contributory Infringement, Hatch-Waxman, Life Sciences, Patent Infringement, Patent Litigation

See all updates »

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant…more

Biologics, Biosimilars, BPCIA, Drug Approvals, FDA Approval

See all updates »

Webinar | Addressing Bias in the Legal Industry

The average person makes an estimated 35,000 decisions each day. With our unconscious minds driving many of these decisions, both conscious and unconscious biases are a powerful force in shaping our behavior. In this webinar,…more

Bias, Defense Strategies, Intellectual Property Litigation, Intellectual Property Protection, Jury Trial

See all updates »

FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

On November 7, the Federal Trade Commission announced that it is challenging more than 100 patents held by 10 branded drug companies as improperly or inaccurately listed in the Food and Drug Administration’s Orange Book. The…more

Competition, Enforcement Actions, FDA Approval, Federal Trade Commission (FTC), Food and Drug Administration (FDA)

See all updates »

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

On September 27, 2023, Judge Richard Andrews, following a three-day bench trial, determined that several patents asserted by Allergan against Sun Pharmaceuticals and MSN Laboratories were invalid for lack of written description…more

Allergan Inc, Obviousness, Obviousness-Type Double Patenting (ODP), Patent Invalidity, Patent Litigation

See all updates »

USPTO Proposes Rules Updating Motion to Amend Practice Before the PTAB

The United States Patent and Trademark Office (USPTO) published a Notice of Proposed Rulemaking (NPRM) today proposing to update its rules governing motions to amend before the Patent Trial and Appeal Board (PTAB)…more

America Invents Act, Comment Period, Inter Partes Review (IPR) Proceeding, Motion to Amend, NPRM

See all updates »

I’m Ready to Sue for Patent Infringement—But First, Do I Have the Right Plaintiffs?

You think you are ready to assert your patent rights. You have done your due diligence, carefully selected the proper defendants, and have selected the proper venue for your case. Now what? What patent plaintiffs often overlook…more

Patent Infringement, Patent Litigation

See all updates »

ITC Monthly Wrap-Up: September 2023

This month’s ITC Wrap-Up reviews recent developments in the Commission’s scope of authority to review (1) infringement by “alternative” products and (2) infringement of claims other than those a product was accused of…more

Infringement, International Trade, International Trade Commission (ITC), Investigations, Patent Infringement

See all updates »

Webinar | FTC Challenges to Orange Book Listings: Considerations for Patent Holders

On November 7, 2023, the Federal Trade Commission announced that it is challenging more than 100 patents held by 10 branded drug companies as improperly or inaccurately listed in the Food and Drug Administration's Orange Book…more

Federal Trade Commission (FTC), Food and Drug Administration (FDA), FTC Act, Life Sciences, Orange Book

See all updates »

Fish Post-Grant Radio: Episode #13: Rick Bisenius

This episode of Fish Post-Grant Radio features Fish attorneys Stuart Nelson – in his final episode as host – and Rick Bisenius, who will take over from Stuart going forward. In it, they discuss major precedential PTAB decisions,…more

America Invents Act, Inter Partes Review (IPR) Proceeding, Motion to Amend, Patent Infringement, Patent Litigation

See all updates »

Webinar | The Basics of TTAB Opposition and Cancellation Proceedings

Suppose that another person or entity has applied for a trademark registration at the United States Patent and Trademark Office (USPTO) that is similar to your trademark. Or, perhaps, you learn that another person or entity has…more

Intellectual Property Protection, Trademark Application, Trademark Cancellation, Trademark Litigation, Trademark Opposition Proceedings

See all updates »

The Top Three Things Foreign Companies Should Keep in Mind When Considering IPR

Being sued for patent infringement in the U.S. can be confusing, especially for foreign companies with limited litigation experience. Even more confusing are the multiple options and venues available for responding to patent…more

Administrative Law Judge (ALJ), Burden of Proof, Foreign Entities, Inter Partes Review (IPR) Proceeding, Litigation Strategies

See all updates »

IP and Cannabis: The Current Landscape

Cannabis is a rapidly growing industry; in 2019, overall sales of cannabis products legal under state law were estimated to be worth $13.6 billion, with an expected increase to $29.7 billion by 2025. While marijuana remains a…more

Cannabidiol (CBD) oil, Cannabis Products, Controlled Substances, Cosmetics, Dietary Supplements

See all updates »

Texas Patent Litigation Monthly Wrap-Up: June 2023

Apax Beam Technologies LLC v. ZTE Corporation, No. 2:22-CV-000310JRG-RSP (E.D. Tex. Jun. 14, 2023) Defendants’ Motion to Stay Pending Inter Partes Review - Defendants Samsung Electronics Co, Ltd. and Samsung Electronics…more

FRAND, Inter Partes Review (IPR) Proceeding, Patent Litigation, Patent Trial and Appeal Board, Patents

See all updates »

USPTO Issues Proposed Rules on Director Review

On April 16, the United States Patent and Trademark Office (USPTO) published a Notice of Proposed Rulemaking (NPRM) regarding Director Review of Patent Trial and Appeal Board (PTAB) decisions…more

Administrative Review, NPRM, Patent Trial and Appeal Board, Patents, Proposed Rules

See all updates »

What is Patentable Subject Matter?

Patent eligibility is the first of three hurdles to be cleared in obtaining a patent (the other two are novelty and non-obviousness). This post is the first of a series that provides a digest of the law of…more

Patent Act, Patent-Eligible Subject Matter, Patents

See all updates »

EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO

Challenges to the validity of the “Patent Cooperation Treaty joint applicant” have been a problem for many applicants at the European Patent Office. On October 10, 2023, the EPO’s highest authority, the Enlarged Board of Appeal,…more

EU, European Patent Convention, European Patent Office, Paris Convention, Patent Cooperation Treaty

See all updates »

Minnesota Patent Litigation Wrap-Up: Q3 2023

This post continues our summary of substantive orders in patent litigation in the District of Minnesota. This summary includes a motion to compel production of chemical intermediates from an overseas manufacturer in…more

Bristol-Myers Squibb, Foreign Corporations, Motion to Compel, Patent Infringement, Patent Litigation

See all updates »

Strategic IP Considerations of Batteries and Energy Storage Solutions

The lithium-ion battery, introduced commercially in 1991, revolutionized the consumer electronics industry. Compared with older battery technologies, the lithium-ion battery was lightweight and compact, had high energy density,…more

Batteries, Biden Administration, Charging Stations, Defend Trade Secrets Act (DTSA), Electric Vehicles

See all updates »

Texas Patent Litigation Monthly Round-Up - March 2022

This post summarizes two recent Eastern District of Texas opinions regarding the award of attorneys’ fees under 35 U.S.C. § 285. Traxcell Technologies, LLC v. AT&T, Inc. et al, 2-17-cv-00718 (EDTX Mar. 29, 2022) (Roy S…more

35 U.S.C. § 285, Attorney's Fees, Damages, Exceptional Case, Patent Infringement

See all updates »

USPTO Says AI-Assisted Inventions Not Categorically Unpatentable in New Guidance

Is an invention developed with the assistance of artificial intelligence (AI) patentable? On February 13, the United States Patent and Trademark Office (USPTO) issued guidance that helps to answer this question while also…more

Artificial Intelligence, Computer-Related Inventions, Innovative Technology, Intellectual Property Protection, Inventions

See all updates »

What the FTC’s Ban on Noncompete Agreements Means for Trade Secrets

On April 23, the Federal Trade Commission (FTC) issued a final rule that would ban the use of noncompete agreements in most employment contracts nationwide. Hailed by the Commission as a measure to promote competition, protect…more

Confidential Information, Employment Contract, Federal Trade Commission (FTC), Final Rules, Former Employee

See all updates »

Massachusetts Patent Litigation Wrap Up – December 2017

This post is part of a monthly series summarizing notable activity in patent litigation in the District of Massachusetts, including short summaries of substantive orders. StrikeForce Techs., Inc. v. Vasco Data Security, Inc.,…more

Motion to Dismiss, Motion To Stay, Patent Infringement, Patent Invalidity, Patent Litigation

See all updates »

EDTX & NDTX Monthly Wrap-Up: July 2021

This month’s EDTX & NDTX Wrap-Up summarizes two decisions from the Eastern District of Texas that issued in late June and in July. In the first decision, Judge Schroeder addresses the scope of IPR estoppel related to system art…more

Inter Partes Review (IPR) Proceeding, Patent Litigation, Patents, Personal Jurisdiction, Subject Matter Jurisdiction

See all updates »

Where Juries Come From

It’s the first day of trial and your team is ready to go. Typically, 48 citizens stream into the courtroom.  A small subset of those people will determine your fate—and whether your business unit will be satisfied with two years…more

Juror, Jury Trial, Trial Practice Guidance, Trial Preparation

See all updates »

Section 101: Cert. Denied … Now What?

Since the Supreme Court’s decisions in Mayo Collaborative Services, LLC v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012) and Alice Corp. v. CLS Bank, 573 U.S. 208 (2014), lower courts and the United States Patent and…more

Denial of Certiorari, Diagnostic Method, Patent Litigation, Patent-Eligible Subject Matter, Patents

See all updates »

USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

One year ago, the United States Patent and Trademark Office (USPTO) issued an Advance Notice of Proposed Rulemaking (ANPRM) that set forth several ideas related to America Invents Act (AIA) proceedings before the Patent Trial…more

Administrative Procedure, Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Inter Partes Review (IPR) Proceeding, NPRM

See all updates »

How Biosimilars Are Approved and Litigated: Patent Dance Timeline

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an FDA-approved reference biological product. Biosimilar applicants have a number of choices to make on the path to…more

Biologics, Biosimilars, BPCIA, Commercial Marketing, Food and Drug Administration (FDA)

See all updates »

Fish Obtains First PGR Reversal at Federal Circuit in Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.

Fish and Richardson has obtained the first appellate reversal of a Post-Grant Review (PGR) proceeding at the United States Court of Appeals for the Federal Circuit since the proceedings were first implemented in 2012. Fish’s…more

Patent Litigation, Patent Trial and Appeal Board, Patents, Pharmaceutical Patents, Post-Grant Review

See all updates »

PTAB Designates Previous Board Decision in Westlake Services v. Credit Acceptance as Precedential

On January 12, 2016, the Patent Trial and Appeal Board (PTAB) designated as precedential a previous Board decision in Westlake Services, LLC v. Credit Acceptance Corp., CBM2014-00176, Paper 28 (PTAB May 14, 2015), clarifying the…more

Covered Business Method Patents, Estoppel, Patent Trial and Appeal Board, Patents

See all updates »

2023 Post-Grant Annual Report

2023 was a busy year at the Patent Trial and Appeal Board, as post-grant practice continued to evolve at a rapid pace. At the United States Patent and Trademark Office, there were big developments in Director Review and proposed…more

Administrative Procedure Act, Advanced Notice of Proposed Rulemaking (ANPRM), Estoppel, Inter Partes Review (IPR) Proceeding, Obviousness

See all updates »

Amgen Appeals Loss of Neulasta® and Neupogen® Litigation

On October 3, 2016, Amgen filed a Notice of Appeal in the U.S. District Court for the Southern District of Florida and thereby laid the groundwork for its next move in the ongoing Amgen v. Apotex dispute. (D.I. 272.) - The…more

Amgen, Apotex, Biosimilars, BPCIA, Food and Drug Administration (FDA)

See all updates »

I’m Ready to Sue for Patent Infringement—But First, Do I Have the Right Plaintiffs?

You think you are ready to assert your patent rights. You have done your due diligence, carefully selected the proper defendants, and have selected the proper venue for your case. Now what? What patent plaintiffs often overlook…more

Patent Infringement, Patent Litigation

See all updates »

USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

One year ago, the United States Patent and Trademark Office (USPTO) issued an Advance Notice of Proposed Rulemaking (ANPRM) that set forth several ideas related to America Invents Act (AIA) proceedings before the Patent Trial…more

Administrative Procedure, Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Inter Partes Review (IPR) Proceeding, NPRM

See all updates »

Texas Patent Litigation Monthly Wrap-Up: February 2023

This post summarizes some of the significant developments in the Western District of Texas and the Eastern District of Texas for the month of February 2023…more

Apple, Patent Litigation, Patents, Samsung, Toyota

See all updates »

Need-to-Knows of the New Copyright Claims Board for Small-Value Copyright Claims

The Copyright Claims Board is a new forum for copyright holders to pursue straightforward, low-economic-value claims related to copyright infringement. The CCB may be an attractive option for copyright owners who are priced out…more

Administrative Review Board, Copyright, Copyright Infringement, Copyright Office, Dispute Resolution

See all updates »

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

On December 7, the Biden administration announced a proposed framework for determining whether the government may exercise its march-in rights to license pharmaceutical patents to third parties if it determines that the price of…more

Bayh-Dole Act, Biden Administration, Life Sciences, March-in-Rights, Patents

See all updates »

The Defend Trade Secrets Act: The Year in Numbers

On May 11, 2016, President Barack Obama signed into law the Defend Trade Secrets Act (DTSA). Before the passage of the DTSA, each state had its own trade secret regime, whether through some variation of the Uniform Trade…more

Corporate Counsel, Defend Trade Secrets Act (DTSA), Misappropriation, Trade Secrets, Uniform Trade Secrets Acts

See all updates »

Section 101: Cert. Denied … Now What?

Since the Supreme Court’s decisions in Mayo Collaborative Services, LLC v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012) and Alice Corp. v. CLS Bank, 573 U.S. 208 (2014), lower courts and the United States Patent and…more

Denial of Certiorari, Diagnostic Method, Patent Litigation, Patent-Eligible Subject Matter, Patents

See all updates »

Webinar | Addressing Bias in the Legal Industry

The average person makes an estimated 35,000 decisions each day. With our unconscious minds driving many of these decisions, both conscious and unconscious biases are a powerful force in shaping our behavior. In this webinar,…more

Bias, Defense Strategies, Intellectual Property Litigation, Intellectual Property Protection, Jury Trial

See all updates »

Unlocking California’s Trade Secret Identification Requirement Under California Code of Civil Procedure Sec. 2019.210 – Part 2

California trade secret law presents a unique statutory framework among state and federal trade secret laws that requires plaintiffs to identify the misappropriated trade secrets before discovery commences. A previous post…more

Breach of Contract, California, Confidential Information, Discovery, Misappropriation

See all updates »

A Lucky Day for Lucky Brand: U.S. Supreme Court Rejects Second Circuit's Defense Preclusion Test - The Court rules in favor of Lucky Brand Dungarees, Inc. in a decades-long trademark dispute with Marcel Fashions Group, Inc.

On May 14, 2020, the U.S. Supreme Court ruled in Lucky Brand Dungarees Inc., et al. v. Marcel Fashions Group, Inc. that Lucky Brand was not precluded from raising a defense that it could have raised in a previous trademark…more

Claim Preclusion, Collateral Estoppel, Counterclaims, Defense Preclusion, Fashion Branding

See all updates »

USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

One year ago, the United States Patent and Trademark Office (USPTO) issued an Advance Notice of Proposed Rulemaking (ANPRM) that set forth several ideas related to America Invents Act (AIA) proceedings before the Patent Trial…more

Administrative Procedure, Advanced Notice of Proposed Rulemaking (ANPRM), America Invents Act, Inter Partes Review (IPR) Proceeding, NPRM

See all updates »

Webinar | What Med Device Companies Need to Know About Litigating in the ITC

Due to rapid advancements in diagnostics and an aging population, the U.S. medical device market is anticipated to grow from $192.78 billion in 2023 to $291.04 billion by 2030. Roughly a third of the medical devices in the U.S…more

Customs and Border Protection, Imports, International Trade Commission (ITC), Medical Devices, Patent Infringement

See all updates »

ITC Monthly Wrap-Up: January 2024

This month’s ITC wrap-up focuses on an initial determination in an investigation regarding constitutional standing, which is a requirement at the Commission as in federal court…more

Administrative Law Judge (ALJ), International Trade Commission (ITC), Investigations, IP License, Patent Infringement

See all updates »

Texas Patent Litigation Monthly Wrap-Up: April 2023

Four subjects stood out in patent litigation in Texas in April 2023: (1) applicability of the customer-suit exception to the first-to-file rule; (2) the level of ties a reasonable royalty methodology must have to the facts of…more

Estoppel, First-to-File, Inter Partes Reexamination, Inter Partes Review (IPR) Proceeding, Patent Infringement

See all updates »

Post-Trial Motions: No Rest for the Post-Trial Attorney

A party’s case-in-chief is closed or a verdict has just been delivered, and now it’s time for a variety of critically important post-trial motions to preserve a victory or overturn a defeat, or at least to preserve the right to…more

JMOL, Post Trial Motions

See all updates »

ITC Monthly Wrap-Up: June 2023

In June, complainants filed four complainants with the Commission—Certain Portable Battery Jump Starters and Components Thereof (II), Inv. No. 337-TA-1359; Certain Semiconductor Devices and Products Containing the Same, Inv. No…more

International Trade Commission (ITC), Misappropriation, Patent Litigation, Patents, Pharmaceutical Industry

See all updates »

Webinar | Protecting Your Femtech IP

Femtech is a growing industry that develops solutions to women’s healthcare issues that historically have been underfunded, under researched, and misunderstood. It focuses primarily on conditions that present differently in…more

Healthcare, Intellectual Property Protection, Medical Devices, Pharmaceutical Industry, Software

See all updates »

Webinar | How Standardization, SEPs, and Patent Pools Can Benefit the EV and Battery Industries

Technical standards are industry norms that enable interoperability, promote safety, and create economies of scale. While technical standards are intended to be implemented on a wide scale in the mass consumer market, many…more

Charging Stations, Electric Vehicles, Intellectual Property Protection, IP License, Lithium Batteries

See all updates »

USPTO Launches Semiconductor Technology Pilot Program

On December 1, the United States Patent and Trademark Office launched the Semiconductor Technology Pilot Program. As part of the Office’s efforts to support the Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act…more

Good Faith, Inventions, Inventors, Patent Applications, Patents

See all updates »

EDTX & NDTX Monthly Wrap-Up – February 2021

This month, the Eastern District of Texas issued four opinions across two cases that considered motions to strike portions of expert reports that were based on allegedly untimely disclosures…more

Discovery, Mobile Apps, Patent Infringement, Patent Litigation, Patents

See all updates »

What’s New in Director Review?

In July, the United States Patent and Trademark Office announced several changes to the interim process for Director review of Patent Trial and Appeal Board decisions. Originally established shortly after the Supreme Court’s…more

Administrative Appeals, Administrative Review, Directors, Patent Trial and Appeal Board, PTAB Precedential Opinion Panel (POP)

See all updates »

Webinar | Trademark & Copyright 2023 Year in Review

2023 brought several notable developments in trademark and copyright law, including cases that touched on artificial intelligence and generative AI, copyright fair use, and the extraterritorial application of the Lanham Act. On…more

Andy Warhol Foundation for the Visual Arts Inc v Goldsmith, Intellectual Property Protection, Jack Daniels Properties Inc v VIP Products LLC, Lanham Act, Rogers Test

See all updates »

How Biosimilars Are Approved and Litigated: Patent Dance Timeline

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an FDA-approved reference biological product. Biosimilar applicants have a number of choices to make on the path to…more

Biologics, Biosimilars, BPCIA, Commercial Marketing, Food and Drug Administration (FDA)

See all updates »

2019 Post-Grant Report

The Patent Trial and Appeal Board (PTAB) remains the forum of choice for challenging the validity of patent claims. However, it is notable that a comparison of 2019 and 2018 statistics reveals about a 30 percent decline in…more

America Invents Act, Patent Trial and Appeal Board, Patents, Post-Grant Review, Trial Practice Guidance

See all updates »

Webinar | What Med Device Companies Need to Know About Litigating in the ITC

Due to rapid advancements in diagnostics and an aging population, the U.S. medical device market is anticipated to grow from $192.78 billion in 2023 to $291.04 billion by 2030. Roughly a third of the medical devices in the U.S…more

Customs and Border Protection, Imports, International Trade Commission (ITC), Medical Devices, Patent Infringement

See all updates »

Hatch-Waxman 101

Pharmaceutical patents have proven to be a highly effective incentive for groundbreaking innovation. However, corresponding drug prices have long been an animating issue in American law and policy…more

Abbreviated New Drug Application (ANDA), Food and Drug Administration (FDA), Hatch-Waxman, Life Sciences, Patents

See all updates »

ITC Monthly Wrap-Up: February 2024

In February, the International Trade Commission (ITC) instituted three new Section 337 investigations: Certain Oil Vaporizing Devices, Components Thereof, and Products Containing the Same, 337-TA-1392; Certain Network Equipment…more

Indefiniteness, International Trade Commission (ITC), Markman Hearing, Patent Invalidity, Patents

See all updates »

ITC Monthly Wrap-Up: November 2023

This month’s International Trade Commission wrap-up focuses on the circumstances in which a complainant can amend its complaint. In particular, on November 2, 2023, Administrative Law Judge Moore denied a complainant’s motion…more

Administrative Law Judge (ALJ), False Advertising, Intellectual Property Protection, International Trade Commission (ITC), Lanham Act

See all updates »

Patent Local Rules: Knowing Them Well Can Make Litigating Your Case Smoother

Federal district courts throughout the country have enacted “patent local rules” that streamline how patent cases are litigated.  Here we provide a brief description of what they are, how they are applied, and some reasons why…more

Local Rules, Patent Litigation, Patents

See all updates »

Webinar | Protecting and Enforcing Your Trade Secrets in a Global Economy

In the interconnected, global environment of business, trade secret information regularly crosses international boundaries, and trade secret misappropriation can occur anywhere in the world. Trade secret holders should thus…more

Asset Protection, Defend Trade Secrets Act (DTSA), Intellectual Property Protection, International Trade Commission (ITC), Misappropriation

See all updates »

Judge Connolly’s New Standing Order Requiring Disclosure Behind Patent Assertion Entities Is Showing It Has Teeth

On August 17, 2022, Chief Judge Colm F. Connolly of the District of Delaware issued an order in which he questioned the sufficiency of the plaintiff’s disclosure of financially interested parties in Longbeam Technologies LLC. v…more

Disclosure Requirements, Federal Rules of Civil Procedure, Federal Trade Commission (FTC), Fee-Shifting, IP License

See all updates »

Federal Circuit Panel Holds Hatch-Waxman Venue Under the Second Prong of § 1400(b) is Based on Actions Related to ANDA Submission

Valeant Pharmaceuticals North America LLC v. Mylan Pharmaceuticals Inc. Last Thursday, a Federal Circuit panel issued a decision applying a narrow reading of the patent venue statute, 28 U.S.C. § 1400(b), in a Hatch-Waxman case…more

Abbreviated New Drug Application (ANDA), Generic Drugs, Hatch-Waxman, Mylan Pharmaceuticals, Patent Infringement

See all updates »

Webinar | How Standardization, SEPs, and Patent Pools Can Benefit the EV and Battery Industries

Technical standards are industry norms that enable interoperability, promote safety, and create economies of scale. While technical standards are intended to be implemented on a wide scale in the mass consumer market, many…more

Charging Stations, Electric Vehicles, Intellectual Property Protection, IP License, Lithium Batteries

See all updates »

Minimizing Patent TRO and PI Risk in Europe

Do you fear the possibility of a temporary restraining order or a preliminary injunction involving patent infringement allegations in Europe? Those provisional measures are more common in Europe than in the United States…more

EU, Jurisdiction, Patent Infringement, Patent Litigation, Patents

See all updates »

The Patent Litigation Process: The Complaint

Like all litigation, patent litigation begins when a plaintiff files a complaint against a defendant. Typically, a patentee or a licensee files a complaint for patent infringement. When drafting a complaint, the plaintiff must…more

Litigation Strategies, Patent Infringement, Patent Litigation, Patents, Subject Matter Jurisdiction

See all updates »

This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide

JD Supra Privacy Policy

Updated: Dec 28, 2021:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and companies and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
150 Harbor Drive, #2760
Sausalito, CA 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
150 Harbor Drive, #2760
Sausalito, CA 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide